1. Home
  2. CRMT vs SLN Comparison

CRMT vs SLN Comparison

Compare CRMT & SLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo America's Car-Mart Inc

CRMT

America's Car-Mart Inc

N/A

Current Price

$18.89

Market Cap

208.2M

ML Signal

N/A

Logo Silence Therapeutics Plc American Depository Share

SLN

Silence Therapeutics Plc American Depository Share

N/A

Current Price

$6.23

Market Cap

236.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CRMT
SLN
Founded
1981
1994
Country
United States
United Kingdom
Employees
N/A
116
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
208.2M
236.2M
IPO Year
2026
N/A

Fundamental Metrics

Financial Performance
Metric
CRMT
SLN
Price
$18.89
$6.23
Analyst Decision
Buy
Buy
Analyst Count
2
5
Target Price
$37.00
$42.60
AVG Volume (30 Days)
76.4K
190.1K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
147.36
N/A
EPS
N/A
N/A
Revenue
$1,390,932,000.00
N/A
Revenue This Year
$2.41
N/A
Revenue Next Year
$4.65
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$17.32
$1.97
52 Week High
$62.55
$7.78

Technical Indicators

Market Signals
Indicator
CRMT
SLN
Relative Strength Index (RSI) 34.83 64.25
Support Level $17.78 $5.79
Resistance Level $28.59 $6.21
Average True Range (ATR) 1.37 0.57
MACD -0.09 0.14
Stochastic Oscillator 27.78 83.13

Price Performance

Historical Comparison
CRMT
SLN

About CRMT America's Car-Mart Inc

America's Car-Mart Inc is an automotive retailer in the U.S. focused exclusively on the Integrated Auto Sales and Finance segment of the used car market. The company's operations are principally conducted through its two operating subsidiaries, America's Car Mart Inc and Colonial Auto Finance. It predominantly sells older model used vehicles and provides financing for substantially all of its customers. It earns revenue from the sale of used vehicles and, in the majority of cases, a related service contract and an accident protection plan product, as well as interest income and late fees from the related financing.

About SLN Silence Therapeutics Plc American Depository Share

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA. Using its mRNAi GOLD platform, the company has generated siRNA product candidates both for internal development pipeline as well as for out-licensed programs with third-party collaborators. Its wholly owned pipeline is focused on three therapeutic areas: cardiovascular disease, hematology, and rare diseases. The different product candidates in its pipeline are Divesiran (SLN124), a siRNA product candidate that has the potential to treat several hematological disorders; Zerlasiran (SLN360), being developed as a potential treatment to reduce cardiovascular issues; SLN-312; SLN-548; and multiple other programs.

Share on Social Networks: